Search research articles
Contact Us
Filters
Showing results (531-540 of 792) with videos related to
Page
of 80
Sort By:
Genes, Chromosomes & Cancer
|
October 18, 2016
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma
Jonas Leichsenring, Anna-Lena Volckmar, Nikolaus Magios, et al.
Cancer Research
|
March 9, 2005
Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer
Carsten Müller-Tidow, Sven Diederichs, Etmar Bulk, et al.
Transplantation Proceedings
|
September 28, 2020
Hand-Assisted Retroperitoneoscopic Donor Nephrectomy Compared to Anterior Approach Open Donor Nephrectomy: Improved Long-Term Physical Component Score in Health-Related Quality of Life in Living Kidney Donors
Roger Wahba, Frank Vitinius, Bianca Walczuch, et al.
Acta Biomaterialia
|
April 24, 2012
Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells
Ana M C Barradas, Kristina Lachmann, Gregor Hlawacek, et al.
BMC Gastroenterology
|
March 9, 2022
Consensus care recommendations for alfapump<sup>®</sup> in cirrhotic patients with refractory or recurrent ascites
Niels Kristian Aagaard, Massimo Malago, Andrea De Gottardi, et al.
Oncogene
|
September 13, 2003
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer
Ping Ji, Sven Diederichs, Wenbing Wang, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 7, 2026
Sleep complaints and genetic risk of Alzheimer's disease in older women: associations with memory and tau deposition
Kitty K Lui, Xin Wang, Melanie A Dratva, et al.
Investigational New Drugs
|
November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
Johanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
NPJ Precision Oncology
|
December 8, 2021
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, et al.
Clinical Lung Cancer
|
December 29, 2016
Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer
Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, et al.
Page
of 80
Search research articles
Search
Showing results (531-540 of 792) with videos related to
Sort By:
Page
of 80
Genes, Chromosomes & Cancer
|
October 18, 2016
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma
Jonas Leichsenring, Anna-Lena Volckmar, Nikolaus Magios, et al.
Cancer Research
|
March 9, 2005
Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer
Carsten Müller-Tidow, Sven Diederichs, Etmar Bulk, et al.
Transplantation Proceedings
|
September 28, 2020
Hand-Assisted Retroperitoneoscopic Donor Nephrectomy Compared to Anterior Approach Open Donor Nephrectomy: Improved Long-Term Physical Component Score in Health-Related Quality of Life in Living Kidney Donors
Roger Wahba, Frank Vitinius, Bianca Walczuch, et al.
Acta Biomaterialia
|
April 24, 2012
Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells
Ana M C Barradas, Kristina Lachmann, Gregor Hlawacek, et al.
BMC Gastroenterology
|
March 9, 2022
Consensus care recommendations for alfapump<sup>®</sup> in cirrhotic patients with refractory or recurrent ascites
Niels Kristian Aagaard, Massimo Malago, Andrea De Gottardi, et al.
Oncogene
|
September 13, 2003
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer
Ping Ji, Sven Diederichs, Wenbing Wang, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 7, 2026
Sleep complaints and genetic risk of Alzheimer's disease in older women: associations with memory and tau deposition
Kitty K Lui, Xin Wang, Melanie A Dratva, et al.
Investigational New Drugs
|
November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
Johanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
NPJ Precision Oncology
|
December 8, 2021
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, et al.
Clinical Lung Cancer
|
December 29, 2016
Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer
Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, et al.
Page
of 80